COLLEGIUM PHARMACEUTICAL, INC short interest in 2026
In 2026, COLLEGIUM PHARMACEUTICAL, INC's disclosed short interest ran from 17.67% of shares outstanding on 15 Jan 2026 to 17.43% on 15 Sep 2026, a change of -0.24 percentage points. The year's high was 20.04% on 14 Aug 2026 and its low 13.47% on 13 Mar 2026, averaging 16.91% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.80 days on 29 May 2026. Full history: COLLEGIUM PHARMACEUTICAL, INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 17.67% (15 Jan 2026)
- End of year
- 17.43% (15 Sep 2026)
- Change
- -0.24 pp
- High
- 20.04% (14 Aug 2026)
- Low
- 13.47% (13 Mar 2026)
- Average
- 16.91%
- Highest days to cover
- 17.80 (29 May 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 17.67% | 10.81 | |
| 30 Jan 2026 | 15.17% | 9.43 | |
| 13 Feb 2026 | 15.03% | 15.75 | |
| 27 Feb 2026 | 14.48% | 12.99 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 13.47% | 7.39 | |
| 31 Mar 2026 | 17.42% | 7.85 | |
| 15 Apr 2026 | 19.00% | 10.74 | |
| 30 Apr 2026 | 18.30% | 14.44 | |
| 15 May 2026 | 18.39% | 11.18 | 10-Q filed, results (8-K) |
| 29 May 2026 | 17.46% | 17.80 | |
| 15 Jun 2026 | 16.43% | 13.07 | |
| 30 Jun 2026 | 16.85% | 10.84 | |
| 15 Jul 2026 | 16.14% | 11.19 | |
| 31 Jul 2026 | 15.61% | 17.35 | |
| 14 Aug 2026 | 20.04% | 6.66 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 18.63% | 8.08 | |
| 15 Sep 2026 | 17.43% | 6.03 |
See also: COLLEGIUM PHARMACEUTICAL, INC's full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.